Prof Laura Itzhaki has been named of one of the ‘50 Movers and Shakers in BioBusiness 2019’,
Laura is CSO and Founder of PolyProx Therapeutics – a company designing biotherapeutics to destroy faulty proteins in the human body.
She is a Professorial Fellow of Newnham College, and one of the College’s Director of Studies for the Natural Sciences Tripos.
Laura has created a technology to harness the cell’s internal quality-control machinery. Her approach shortcuts cell signals to redirect the machinery to dispose of unwanted proteins, such as proteins in cancer cells that cannot be targeted by conventional drugs. Laura heads a research group in the University of Cambridge, Department of Pharmacology and in 2019 secured £3.4 million seed financing for PolyProx Therapeutics to develop drug candidates.
Newnham is delighted that the impact of Laura’s research and its potential to benefit patients has been recognised in this forum.
Read more about the BioBeat report on the Cambridge Network website